Screener
Theravance Biopharma TBPH Business Segments — Income Tax Expense Benefit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Theravance Biopharma’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 9:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056760
| (In thousands) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total recurring operating expenses | 23,549 | 29,822 |
| Restructuring expenses (including share-based compensation) | 3,633 | — |
| Total operating expenses | 27,182 | 29,822 |
| Loss from operations | (9,483) | (14,434) |
| Interest expense (non-cash) | — | (643) |
| Interest and other income, net | 3,013 | 939 |
| Provision for income tax benefit | 1,537 | 559 |
| Net loss | $(4,933) | $(13,579) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Theravance Biopharma's business segments — income tax expense benefit?
- Theravance Biopharma (TBPH) reported business segments — income tax expense benefit of -$1.54M in Q1 2026.
- How has Theravance Biopharma's business segments — income tax expense benefit changed year-over-year?
- Theravance Biopharma's business segments — income tax expense benefit decreased by 175.0% year-over-year, from -$559K to -$1.54M.
- What is the long-term trend for Theravance Biopharma's business segments — income tax expense benefit?
- Over 2 years (2023 to 2025), Theravance Biopharma's business segments — income tax expense benefit has grown at a 98.5% compound annual growth rate (CAGR), from $5.92M to $23.35M.
- What does business segments — income tax expense benefit mean?
- This reflects the provision for income taxes or the recognition of tax benefits attributable to the segment's financial results. It is essential for calculating the segment's net contribution to the company's after-tax earnings and understanding the tax implications of its operational performance.
Ask your AI about Theravance Biopharma's business segments — income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude